Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective-Reference-Cited by-同舟云学术

Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective

Published:2015 Issue:4 Volume:30 Page:531
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Sohn Seo Young¹,Jang Hye Won²,Cho Yoon Young³,Kim Sun Wook³,Chung Jae Hoon³

Affiliation:

1. Division of Endocrinology, Department of Medicine, Myongji Hospital, Seonam University College of Medicine, Goyang, Korea.

2. Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.3803/EnM.2015.30.4.531

Reference21 articles.

1. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

2. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

3. Thyroid Hormone Withdrawal in Patients with Differentiated Thyroid Carcinoma: A One Hundred Thirty-Patient Pilot Survey on Consequences of Hypothyroidism and a Pharmacoeconomic Comparison to Recombinant Thyrotropin Administration

4. Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer;Clinical Nuclear Medicine;2024-01-19

2. Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis;Cancers;2023-04-27

3. Predictive factors determining incomplete response to radioiodine therapy in patients with differentiated thyroid cancer;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2020-04

5. Initial Adoption of Recombinant Human Thyroid-Stimulating Hormone Following Thyroidectomy in the Medicare Thyroid Cancer Patient Population;Endocrine Practice;2019-01